Skip to content

AIM ImmunoTech Inc.

AIM

CIK 0000946644

← back to feed
Revenue (TTM)
$89K
−48.2% YoY Q1 May 2026
Net Income (TTM)
−$12.81M
+19.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.85
+72.1% YoY Q1 May 2026
Gross Margin
-1,628.1%
Q1 May 2026
Operating Margin
-12,289.9%
Q1 May 2026
Net Margin
-14,388.8%
Q1 May 2026
Free Cash Flow (TTM)
−$13.65M
Q1 May 2026
Cash
$5.82M
Q1 May 2026
Total Debt
$2.3M
Q1 May 2026
Shares Outstanding
14.56M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings